References
- Ekins R P., Newman G B., O'Riordan J LH. Theoretical aspects of ‘saturation’ and radioimmunoassay. Radioisotopes in Medicine: In vitro studies, R L. Hayes, F A. Gowitz, B EP Murphy. US Atomic Energy Commision/Division of Technical Information, Oak Ridge 1967; 59–100
- Rodbard D, Tacey R L. Radioimmunoassay dose interpolation based on the mass action law with antibody heterogeneity. Anal Biochem 1978; 90: 13–21
- Ekins R P. Mathematical treatment of data. Radioimmunoassay Methods, K E. Kirkham, W M. Hunter. Churchill Livingstone, Edinburgh and London 1971; 607–625
- Christensen P, Leyssac P P. A specific radioimmunoassay for PGE, using an antibody with high specificity and a sephadex LH‐20 microcolumn for the separation of prostaglandins. Prostaglandins 1976; 11: 399–420
- Leyssac P P., Christensen P. A study of the effect of stimulated endogenous prostaglandin synthesis on urine flow. osmolar excretion rate, and renin release in hydropenic and saline loaded anesthetized rats. Acta Physiol Scand 1981; 113: 23–31
- Bie P, Warberg J. Effects on intravascular pressures of vasopressin and angiotensin TI in dogs. Am J Physiol 1983; 245: R906–R914
- Poulsen K. Radioimmunoassay for angiotensin II to be used in direct conjunction with renin assay. Scand J Clin Lab Invest 1969; 24: 285–290
- Poulsen K, Jørgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrin Metab 1974; 39: 816–825
- Armitage P. Statistical methods in medical research. Blackwell Scientific Publications, Oxford London 1971
- Ohta Y, Gill I J., III, Leung C S. Volume changes accompanying the antibody‐antigen reaction. Biochemistry 1970; 9: 2708–2713
- Day E D. Advanced Immunochemistry. Williams & Wilkins, Baltimore 1972
- Talmage D W., Cann J R. The chemistry of immunity in health and disease. Charles C. Thomas, Springfield 1961
- Berson S A., Yalow R S. Quantitative aspects of the reaction between insulin and insulin‐binding antibody. J Clin Invest 1959; 38: 1996–2016